Long-term efficacy and safety of two different rhythm control strategies in elderly patients with symptomatic persistent atrial fibrillation

Journal of Cardiovascular Electrophysiology

Volumn 24, Issue 7, 2013, Pages 731-738

  Blandino, Alessandro ^a   Toso, Elisabetta ^a   Scaglione, Marco ^b   Anselmino, Matteo ^a   Ferraris, Federico ^a   Sardi, Davide ^a   Battaglia, Alberto ^a   Gaita, Fiorenzo ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b Cardinal Guglielmo Massaia Hospital   (Italy)

Author keywords

antiarrhythmic drugs; catheter ablation; elderly patients; persistent atrial fibrillation; quality of life; stroke

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLECAINIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PROPAFENONE; SARTAN DERIVATIVE; SOTALOL; VERAPAMIL; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIAC PATIENT; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FATALITY; DRUG RESPONSE; DRUG SAFETY; DRUG WITHDRAWAL; EMBOLISM; ESOPHAGUS FISTULA; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HEART TAMPONADE; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATIENT SAFETY; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PULMONARY VEIN OBSTRUCTION; SINUS RHYTHM; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE; TREATMENT RESPONSE; VASCULAR DISEASE;

ANTIARRHYTHMIC DRUGS; CATHETER ABLATION; ELDERLY PATIENTS; PERSISTENT ATRIAL FIBRILLATION; QUALITY OF LIFE; STROKE;

AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PROSPECTIVE STUDIES; QUALITY OF LIFE; TIME FACTORS;

EID: 84879795898     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12126     Document Type: Article

References (27)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG,: Prevalence, age distribution, and gender of patients with atrial fibrillation: Analysis and implications. Arch Intern Med 1995; 155: 469-473.
2. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE,: Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anticoagulation and risk factors in atrial fibrillation (ATRIA) study. J Am Med Assoc 2001; 285: 2370-2375. (Pubitemid 32424106)
3. Corley SD, Epstein AE, Di Marco JP, Domanski MJ, Geller N, Greene HL, Josephson RA, Kellen JC, Klein RC, Krahn AD, Mickel M, Mitchell LB, Nelson JD, Rosenberg Y, Schron E, Shemanski L, Waldo AL, Wyse DG, AFFIRM Investigators: Relationships between sinus rhythm, treatment, and survival in the atrial fibrillation follow-up investigation of rhythm management (AFFIRM) study. Circulation 2004; 109: 1509-1513. (Pubitemid 38420179)
4. McCormick D, Gurwitz JH, Goldberg RJ, Becker R, Tate JP, Elwell A, Radford MJ,: Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med 2001; 161: 2458-2463. (Pubitemid 33043119)
5. Dayer M, Hardman SM,: Special problems with antiarrhythmic drugs in the elderly: Safety, tolerability, and efficacy. Am J Geriatr Cardiol 2002; 11: 370-375.
6. Kistler P, Sanders P, Fynn S, Stevenson IH, Spence SJ, Vohra JK, Sparks PB, Kalman JM,: Electrophysiologic and electroanatomic changes in the human atrium associated with age. J Am Coll Card 2004; 44: 109-116. (Pubitemid 38968468)
7. Rocken C, Peters B, Jeunemann G, Saeger W, Klein HU, Huth C, Roessner A, Goette A,: An arrhythmogenic substrate for persistent atrial fibrillation. Circulation 2002; 106: 2091-2097. (Pubitemid 35192815)
8. Raviele A, Natale A, Calkins H, Camm JA, Cappato R, Ann Chen S, Connolly SJ, Damiano R Jr, DE Ponti R, Edgerton JR, Haïssaguerre M, Hindricks G, Ho SY, Jalife J, Kirchhof P, Kottkamp H, Kuck KH, Marchlinski FE, Packer DL, Pappone C, Prystowsky E, Reddy VK, Themistoclakis S, Verma A, Wilber DJ, Willems S,: Venice chart international consensus document on atrial fibrillation ablation: 2011 update. J Cardiovasc Electrophysiol 2012; 23: 890-923.
9. Zado E, Callans DJ, Riley M, Hutchinson M, Garcia F, Bala R, Lin D, Cooper J, Verdino R, Russo AM, Dixit S, Gerstenfeld E, Marchlinski FE,: Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J Cardiovasc Electrophysiol 2008; 19: 621-626. (Pubitemid 351858428)
10. Corrado A, Patel D, Riedlbauchova L, Fahmy TS, Themistoclakis S, Bonso A, Rossillo A, Hao S, Schweikert RA, Cummings JE, Bhargava M, Burkhardt D, Saliba W, Raviele A, Natale A,: Efficacy, safety, and outcome of atrial fibrillation ablation in Septuagenarians. J Cardiovasc Electrophysiol 2008; 19: 807-811. (Pubitemid 352032783)
11. Kusumoto F, Prussak K, Wiesinger M, Pullen T, Lynady C,: Radiofrequency catheter ablation of atrial fibrillation in older patients: Outcomes and complications. J Interv Card Electrophysiol 2009; 25: 31-35.
12. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Lappe DL, Muhlestein JB, Nelson J, Day JD,: Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol 2010; 33: 146-152.
13. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
14. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, Coin D, Di Donna P, Giustetto C,: Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation. Circ Arrhythm Electrophysiol 2008; 1: 269-275.
15. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ,: Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. J Am Med Assoc 2001; 285: 2864-2870. (Pubitemid 32537350)
16. Easton JD, Saver JL, Albers GW, Alberts MJ, Chaturvedi S, Feldmann E, Hatsukami TS, Higashida RT, Johnston SC, Kidwell CS, Lutsep HL, Miller E, Sacco RL,: Definition and evaluation of transient ischemic attack: A scientific statement for healthcare professionals from the American Heart Association/American Stroke Association Stroke Council; Council on Cardiovascular Surgery and Anesthesia; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; and the Interdisciplinary Council on Peripheral Vascular Disease. The American Academy of Neurology affirms the value of this statement as an educational tool for neurologists. Stroke 2009; 40: 2276-2293.
17. Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W,: Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 2010; 8: 202-204.
18. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Mahé I, Bergmann JF,: Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: A systematic review of randomized controlled trials. Arch Intern Med 2006; 166: 719-728.
19. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A,: Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005; 111: 1100-1105. (Pubitemid 40365469)
20. O'Neill MD, Wright M, Knecht S, Jais P, Hocini M, Takahashi Y, Jonsson A, Sacher F, Matsuo S, Lim KT, Arantes L, Derval N, Lellouche N, Nault I, Bordachar P, Clémenty J, Haissaguerre M,: Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J 2009; 30: 1105-1112.
21. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Natale A, Packer D, Skanes A, Ambrogi F, Biganzoli E,: Updated worldwide survey on the Methods, Efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.
22. Ouyang F, Tilz R, Chin J, Schmidt B, Wissner E, Zerm T, Neven K, Köktürk B, Konstantinidou M, Metzner A, Fuernkranz A, Kuck KH,: Long-term results of catheter ablation in paroxysmal atrial fibrillation: Lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
23. Chao TF, Lin YJ, Tsao HM, Tsai CF, Lin WS, Chang SL, Lo LW, Hu YF, Tuan TC, Suenari K, Li CH, Hartono B, Chang HY, Ambrose K, Wu TJ, Chen SA,: CHADS(2) and CHA(2)DS(2)-VASc scores in the prediction of clinical outcomes in patients with atrial fibrillation after catheter ablation. J Am Coll Cardiol 2011; 58: 2380-2385.
24. Marrouche NF, Martin DO, Wazni O, Gillinov AM, Klein A, Bhargava M, Saad E, Bash D, Yamada H, Jaber W, Schweikert R, Tchou P, Abdul-Karim A, Saliba W, Natale A,: Phased-array intracardiac echocardiography monitoring during pulmonary vein isolation in patients with atrial fibrillation: Impact on outcome and complications. Circulation 2003; 107: 2710-2716. (Pubitemid 36667245)
25. Kok LC, Mangrum JM, Haines DE, Mounsey JP,: Cerebrovascular complication associated with pulmonary vein ablation. J Cardiovasc Electrophysiol 2002; 13: 764-767. (Pubitemid 34921134)
26. Oral H, Chugh A, Ozaydin M, Good E, Fortino J, Sankaran S, Reich S, Igic P, Elmouchi D, Tschopp D, Wimmer A, Dey S, Crawford T, Pelosi F, Jongnarangsin JK, Bogun F, Morady F,: Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 2006; 114: 759-765. (Pubitemid 44268226)
27. Ablation versus anti-arrhythmic drug therapy for atrial fibrillation Trial (CABANA). Available at: http://clinicaltrials.gov/ct2/show/NCT00911508. Accessed January 19, 2013.